The following represents articles of interest to the Boston real estate community that appeared in various publications during the week.
Certain news links may require site registration or subscription to access the complete article.
Real Estate Articles of Note
North End-area grocery plan gains new life
Boston Herald — August 13, 2010
The long wait for an affordable supermarket for the West End, Beacon Hill and North End neighborhoods could be over.
Retail Sales in U.S. Rise Less Than Economists Estimated
Bloomberg.com — August 13, 2010
Retail sales in U.S. rose less than forecast in July. Photographer: JB Reed/Bloomberg
Sales at U.S. retailers rose less than forecast in July, indicating a lack of jobs is prompting Americans to hold back on spending.
Manhattan Luxury Condos Try FHA Backing in `Game Changer'
Bloomberg.com — August 13, 2010
Whitney Gollinger, marketing chief for a Manhattan condo building with an outdoor movie theater and panoramic city views, is highlighting a different amenity to spur sales: the financial backing of the federal government.
Distressed hotel, multi-family sales driving prices.
Boston Business Journal — August 11, 2010
It’s no secret that commercial real estate prices are falling, however a new report indicates that much of the decline is being driven by distressed-property sales in the hard-hit hospitality and multifamily markets.
CRE Outlook Choppy, Uneven for Cities, Property Types and Firms
CoStar Group — August 11, 2010
The near-term outlook for the commercial real estate market may be clouded over concerns that stronger job creation is needed to support the nascent economic growth, the impact from possible deflation and the winding down of government stimulus, but its prospects remain somewhat bullish over the longer term. However, most expect the economy to recover in an uneven fashion, characterized by wide variations among markets, property types and firms, according to a new crop of CRE outlooks issued this summer.
Biotechs have big appeal for drug makers
The Boston Globe — August 11, 2010
Genzyme Corp., which is locked in merger talks with French drug maker Sanofi-Aventis SA, is not the first major Massachusetts biotechnology company to be pursued by a major pharmaceutical company. And it likely will not be the last.
City "Innovation District" lacks fast 'net
Boston Business Journal — August 9, 2010
Bocoup LLC has everything Mayor Thomas M. Menino could want for an innovation district. The web development consultancy, which does business as Bocoup Labs, is run by a couple of open-source pros who are wired in with celebrity developers and the global open web standards community headquartered at MIT’s World Wide Web Consortium.
Zillow: Hub Home Value Index Rises In Q2
Banker & Tradesman — August 9, 2010
Home values in the Hub defied a nationwide trend, increasing 3.4 percent year-over-year in the second quarter, a new report found.
Boston's CRE bodes well for credit rating.
Boston Business Journal — August 9, 2010
Boston is among a select class of so-called Global Gateway cities where commercial real estate values and occupancy rates are faring better than other major metros in the United States, a situation that should keep the city and its myriad government agencies on solid financial footing until the economy rebounds.
Colliers Meredith & Grew in the News
Biogen’s relocation doesn’t mean Cambridge’s biotech cluster is losing its luster
The Patriot Ledger — August 11, 2010
With the relocation of its headquarters to Weston this summer, Biogen Idec became the latest in a string of Cambridge biotech firms who have sought cheaper real estate in the suburbs. Shire shipped its local headquarters to Lexington, for example, and Alkermes moved to Waltham.
|